Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (9) GO Terms (2) Nucleotides (82) Proteins (47) Interactants (5) Wiki
XB-GENEPAGE-986046

Papers associated with slc28a3



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

HPLC reveals novel features of nucleoside and nucleobase homeostasis, nucleoside metabolism and nucleoside transport., Altaweraqi RA, Yao SYM, Smith KM, Cass CE, Young JD., Biochim Biophys Acta Biomembr. July 1, 2020; 1862 (7): 183247.


Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia., Errasti-Murugarren E, Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Pérez-Torras S, Kipp H, Koepsell H, Pastor-Anglada M., Mol Pharmacol. July 1, 2012; 82 (1): 59-67.


Mechanism of nucleoside uptake in rat placenta and induction of placental CNT2 in experimental diabetes., Nishimura T, Chishu T, Tomi M, Nakamura R, Sato K, Kose N, Sai Y, Nakashima E., Drug Metab Pharmacokinet. January 1, 2012; 27 (4): 439-46.


A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3., Slugoski MD, Smith KM, Mulinta R, Ng AM, Yao SY, Morrison EL, Lee QO, Zhang J, Karpinski E, Cass CE, Baldwin SA, Young JD., J Biol Chem. September 5, 2008; 283 (36): 24922-34.


A proton-mediated conformational shift identifies a mobile pore-lining cysteine residue (Cys-561) in human concentrative nucleoside transporter 3., Slugoski MD, Ng AM, Yao SY, Smith KM, Lin CC, Zhang J, Karpinski E, Cass CE, Baldwin SA, Young JD., J Biol Chem. March 28, 2008; 283 (13): 8496-507.


Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene., Damaraju S, Zhang J, Visser F, Tackaberry T, Dufour J, Smith KM, Slugoski M, Ritzel MW, Baldwin SA, Young JD, Cass CE., Pharmacogenet Genomics. March 1, 2005; 15 (3): 173-82.


Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)., Badagnani I, Chan W, Castro RA, Brett CM, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE, Carlson EJ, Burchard EG, Giacomini KM., Pharmacogenomics J. January 1, 2005; 5 (3): 157-65.


Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia coli nucleoside-H(+) cotransporter (NupC) produced in Xenopus laevis oocytes., Loewen SK, Yao SY, Slugoski MD, Mohabir NN, Turner RJ, Mackey JR, Weiner JH, Gallagher MP, Henderson PJ, Baldwin SA, Cass CE, Young JD., Mol Membr Biol. January 1, 2004; 21 (1): 1-10.


Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)., Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Hyde RJ, Karpinski E, Cass CE, Baldwin SA, Young JD., Mol Membr Biol. January 1, 2001; 18 (1): 65-72.

???pagination.result.page??? 1